Part B: Immunological Therapies for Lung Cancer


Yucel A. A.

LUNG CANCER: CLINICAL AND SURGICAL SPECIFICATIONS, pp.455-465, 2013 (Journal Indexed in SCI) identifier

  • Publication Type: Article / Article
  • Volume:
  • Publication Date: 2013
  • Title of Journal : LUNG CANCER: CLINICAL AND SURGICAL SPECIFICATIONS
  • Page Numbers: pp.455-465

Abstract

Lung cancer is a disease with very high morbidity and mortality rate. In spite of aggressive treatment modalities, the long-term survival is very low, and these treatments have many toxic adverse effects. Immunological therapies or briefly "immunotherapy" is a promising new therapeutic modality for lung cancer; it can be in the form of active immunization (cancer vaccines), passive immunization (adoptive cell therapy or antibody-based treatment) or immunostimulation.